EFFICACY OF CXCR6 BLOCKADE AS A POTENTIATOR OF ANTI-PD-1 THERAPY FOR THE TREATMENT OF GLIOBLASTOMA

被引：0
|
作者：
Pant, Ayush [1 ]
Saleh, Laura [1 ]
Patel, Kisha [1 ]
Medikonda, Ravi [1 ]
Lim, Michael [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IMMU-13
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] EFFECT OF COMBINED ANTI-PD-1 AND TEMOZOLOMIDE THERAPY IN GLIOBLASTOMA
    Park, Junseong
    Kim, Chang Gon
    Lee, Jae Eun
    Shim, Jin-Kyoung
    Kim, Eui Hyun
    Chang, Jong Hee
    Shin, Eui-Cheol
    Kang, Seok-Gu
    [J]. NEURO-ONCOLOGY, 2018, 20 : 123 - 124
  • [2] Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma
    Park, Junseong
    Kim, Chang Gon
    Shim, Jin-Kyoung
    Kim, Jong Hoon
    Lee, Hoyoung
    Lee, Jae Eun
    Kim, Min Hwan
    Haam, Keeok
    Jung, Inkyung
    Park, Su-Hyung
    Chang, Jong Hee
    Shin, Eui-Cheol
    Kang, Seok-Gu
    [J]. ONCOIMMUNOLOGY, 2019, 8 (01):
  • [3] Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
    Chow, Melvyn T.
    Ozga, Aleksandra J.
    Servis, Rachel L.
    Frederick, Dennie T.
    Lo, Jennifer A.
    Fisher, David E.
    Freeman, Gordon J.
    Boland, Genevieve M.
    Luster, Andrew D.
    [J]. IMMUNITY, 2019, 50 (06) : 1498 - +
  • [4] EFFECT OF ANTI-PD-1 THERAPY COMBINATION ON TEMOZOLOMIDE IN MOUSE GLIOBLASTOMA
    Park, Junseong
    Kim, Chang Gon
    Shim, Jin-Kyong
    Lee, Jae Eun
    Chang, Jong Hee
    Shin, Eui-Cheol
    Kang, Seok-Gu
    [J]. NEURO-ONCOLOGY, 2017, 19 : 116 - 116
  • [5] Anti-PD-1 checkpoint blockade improves the efficacy of a melphalan-based therapy in experimental melanoma
    Kif, Roberta
    Johansson, Junko
    Bagge, Roger Olofsson
    Martner, Anna
    [J]. EJSO, 2021, 47 (09): : 2460 - 2464
  • [6] Role of CXCR3 signaling in response to anti-PD-1 therapy
    Han, Xiao
    Wang, Ying
    Sun, Jing
    Tan, Tao
    Cai, Xiaomin
    Lin, Peinan
    Tan, Yang
    Zheng, Bingfeng
    Wang, Biao
    Wang, Jiawei
    Xu, Lingyan
    Yu, Zhengyi
    Xu, Qiang
    Wu, Xingxin
    Gu, Yanhong
    [J]. EBIOMEDICINE, 2019, 48 : 169 - 177
  • [7] The efficacy and safety of anti-PD-1 therapy in metastatic sarcomas
    Yang, Jilong
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [8] Arterial thrombosis and anti-PD-1 blockade
    Boutros, Celine
    Scoazec, Jean-Yves
    Mateus, Christine
    Routier, Emilie
    Roy, Severine
    Robert, Caroline
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 91 : 164 - 166
  • [9] CS3003, an HDAC6-selective inhibitor, improves anti-PD-1 immune checkpoint blockade therapy efficacy
    Li, Zhenhu
    Ren, Zhaoxiang
    Ma, Jingshu
    Tang, Liang
    Lu, Liang
    Zhu, Ying
    Wu, Yunfei
    Liu, Tiancheng
    Zhang, Juan
    Bao, Yuanwu
    Zhang, Kangyu
    Wei, Changqing
    Chen, Shuhui
    Wang, Xinzhong Jon
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [10] Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment
    Hardcastle, Jayson
    Mills, Lisa
    Malo, Courtney S.
    Jin, Fang
    Kurokawa, Cheyne
    Geekiyanage, Hirosha
    Schroeder, Mark
    Sarkaria, Jann
    Johnson, Aaron J.
    Galanis, Evanthia
    [J]. NEURO-ONCOLOGY, 2017, 19 (04) : 493 - 502
12345